TCRR Shares Outstanding History



Below is a table of the TCRR shares outstanding history going back to 2/14/2019:

Date TCRR Shares Outstanding
2/14/201923.19M
3/25/201923.94M
5/6/201923.94M
7/30/201923.96M
8/6/201917.14M
10/31/201924.03M
3/21/202024.08M
5/3/202138.16M
8/2/202138.18M
11/2/202138.22M
3/18/202238.55M
5/2/202238.55M
8/1/202238.61M
11/1/202238.66M
3/5/202339.24M
5/1/202339.26M

Also see: TCRR Market Cap History
TCRR YTD Return
TCRR Historical Shares Outstanding:
+13.33% CAGR
TCRR Historical Shares Outstanding: +13.33% CAGR

Mouse over chart for data details
2/14/2019 ...5/1/2023
TCR2 Therapeutics is a clinical-stage cell therapy company developing T cell therapies for cancer patients suffering from solid tumors by powering the T cell receptor (TCR) with its TCR Fusion Construct T cells (TRuC-T cells). Co.'s TRuC-T cells recognize and kill cancer cells by using the entire TCR signaling complex. Co.'s TRuC-T cell targeting mesothelin-expressing solid tumors are: gavocabtagene autoleucel, in which Co. is conducting its clinical trial to treat patients with non-small cell lung cancer, ovarian cancer, malignant pleural/peritoneal mesothelioma or cholangiocarcinoma; and TC-510, which incorporates a PD-1:CD28 chimeric switch receptor. We show 16 historical shares outstanding datapoints in our coverage of TCRR's shares outstanding history.

Understanding the changing numbers of TCRR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TCRR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TCRR by allowing them to research TCRR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree TCRR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TCR2 Therapeutics (TCRR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

TCRT Shares Outstanding History
TCRX Shares Outstanding History
TDOC Shares Outstanding History
TECH Shares Outstanding History
TELA Shares Outstanding History
TENX Shares Outstanding History
TERN Shares Outstanding History
TEVA Shares Outstanding History
TFFP Shares Outstanding History
TFX Shares Outstanding History
More Healthcare companies »

 

TCRR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.